Concepedia

Publication | Open Access

mTORC1 inhibition delays growth of neurofibromatosis type 2 schwannoma

DOIFull Paper Access

75

Citations

39

References

2014

Year

Marco Giovannini, N.-X. Bonne, Jérémie Vitte, Fabrice Chareyre, Karo Tanaka, Rocky Adams, Laurel M. Fisher, L. Valeyrie‐Allanore, P. Wolkenstein, Stéphane Goutagny,
Neuro-Oncology

Abstract

Taken together, these results constitute definitive evidence that justifies proceeding with clinical trials using mTORC1-targeted agents in selected patients with NF2 and in patients with NF2-related sporadic tumors.

References

YearCitations

Page 1